InnAccel

Bengaluru, India Founded: 2012 • Age: 14 yrs Minicorn
Diversified medical devices are manufactured for critical and maternal care.

About InnAccel

InnAccel is a Healthcare company based in Bengaluru (India) founded in 2012 by Vibhav Joshi, Sumedh Kaulgud, Nitesh Kumar Jangir, Vijayarajan Alagumalai, and Siraj Dhanani. Diversified medical devices are manufactured for critical and maternal care. InnAccel has raised $6.06 million across 6 funding rounds from investors including ACT Grants, Mount Judi Ventures and B K Achutha. The company has 41 employees. InnAccel was last valued at $35.17 million in April 2022. Its chief executive, as recorded, is Siraj Dhanani. Its Indian entity Innaccel Technologies Private Limited reported revenue of β‚Ή18.80 Cr. InnAccel offers products and services including VapCare, Fetal Lite, and SAANS. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring.

Company details

InnAccel was founded in 2012 in Bengaluru, India, as an RD company in the medical devices sector. Operations center on the development and manufacturing of devices that target unmet needs in critical care and maternal and child health. The companys portfolio includes products designed for these areas, with leadership provided by co-founders holding various director roles.

  • Headquarters Bengaluru, India
  • Employees 41
  • Founders Vibhav Joshi, Sumedh Kaulgud, Nitesh Kumar Jangir, Vijayarajan Alagumalai, Siraj Dhanani
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website innaccel.com
  • Social LinkedIn X Facebook
  • Legal Name Innaccel Technologies Private Limited
  • Date of Incorporation 01 Oct, 2012
  • Jurisdiction Bangalore, Karnataka, India
Key Metrics
  • Annual Revenue
    ₹18.80 Cr

    FY 2024 · +60% YoY

  • Net Loss
    -₹10.53 Cr

    FY 2024 · -56% margin

  • EBITDA
    -₹2.93 Cr

    FY 2024 · -16% margin

  • Total Equity Funding
    $6.06M (USD)

    in 6 rounds

  • Latest Funding Round
    $572.58K (USD), Angel Round

    Apr 2022

  • Investors
    ACT Grants

    & 25 more

  • Employee Count
    41

Products & Services of InnAccel

InnAccel offers a comprehensive portfolio of products and services, including VapCare, Fetal Lite, and SAANS.

VapCare
Critical Care Device

Automated system for secretion management in ventilated patients.

Fetal Lite
Obstetrics Device

AI-powered monitor for fetal heart rate during labor.

SAANS
Neonatology Device

Portable CPAP for neonatal breathing support in remote areas.

Funding Insights of InnAccel

InnAccel has successfully raised a total of $6.06M across 6 strategic funding rounds. The most recent funding activity was a Angel Round of $572.58 thousand completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $6.06M
  • Total Rounds 6
  • Last Round Angel Round β€” $572,581
  • First Round $898,945

    (Jan 2016)

  • Investors Count 26

All 6 funding rounds of InnAccel with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2022$572,581Angel Round$35.17MB K Achutha, Vijay Prasad
Apr 2021$848,394Series A$27.17MMount Judi Ventures
Oct 2020$1.72MSeries A$β€’β€’β€’β€’β€’Mount Judi Ventures
Aug 2020$604,967Grant––
Jan 2017$2.02MSeed$β€’β€’β€’β€’β€’Acunova Life Sciences
Jan 2016$898,945Seed$β€’β€’β€’β€’β€’iTekniqs, Acunova Life Sciences
Valuation history
DateValuationStage
Apr 2022$35.17Mβ€’β€’β€’β€’β€’β€’β€’β€’
Apr 2021$27.17Mβ€’β€’β€’β€’β€’β€’β€’β€’
Oct 2020$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Jan 2017$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Jan 2016$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of InnAccel

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $35.17M (Apr 2022). 26 investors in total: 4 institutional and 22 angel.

Investors in InnAccel

InnAccel has secured backing from 26 investors, including angel and venture fund investors. Prominent investors backing the company include ACT Grants, Mount Judi Ventures and B K Achutha.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital investments in ethical businesses and high-growth sectors in India.
2017mountjudi.comBengaluru, India
Seed capital grants are provided to incubate and accelerate innovations.
2020actgrants.inBengaluru, India
Investments in technology companies are managed by iTekniqs fund.
itekniqs.comBridgewater, United States
Private equity firm focused on multiple sectors
Bengaluru, India

B K Achutha

unknown_04b99e508c28420b9

Vijay Prasad

Angel investor and tech entrepreneur, co-founder of Z47 (Matrix Partners India).
unknown_cab221666de942ebb

Amit Mookim

unknown_8de4f632e38a45f69

Sumit Sadana

unknown_82bc5764b8cb4c58a

Khadija Umar Shaik

unknown_091fa1de251040588

Kiran Pradhan

unknown_0b054248bfd94a729
Premium access

Investor details for InnAccel

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Innaccel Technologies Private Limited (InnAccel)

Innaccel Technologies Private Limited is the primary company behind InnAccel. The board of Innaccel Technologies Private Limited currently have 3 directors; the longest-serving is Vijayarajan Alagumalai, appointed in 2012. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Vijayarajan Alagumalai
DIN 00995196
Director01 Oct 201214 yrs 1 moInnaccel Technologies Private Limited
Siraj Salim Dhanani
DIN 01866863
Director01 Oct 201214 yrs 1 moInnaccel Technologies Private Limited
Sherif Mohammed Kottapurath
DIN 00767696
Director14 Oct 20206 yrs 1 moInnaccel Technologies Private Limited

People of InnAccel

24 people are tracked at InnAccel (11 in leadership, 13 in team); the tracked headcount is 41.

NameRoleGroup
Vibhav Joshi
Co-Founder & Director, ProductLeadership
Sumedh Kaulgud
Co-Founder and Director, Maternal and Child HealthLeadership
Nitesh Kumar Jangir
Co-FounderLeadership
Co-FounderLeadership
Co-Founder & CEOLeadership
Nitesh Jangir
Director, Critical CareLeadership
Abu Saquib Tauheed
Director Design and ManufacturingLeadership
Dinesh Dikshit
Director, FinanceLeadership
A. Vijayarajan
Founder, CTOLeadership
Rajesh Kumar Roy
Head - Application & ServiceLeadership
Shaunak Patel
Chief Commercial OfficerLeadership
Neelanshu Nigam
Sales ManagerTeam
Ravi Kiran
Administrative ExecutiveTeam
Megha Singh
Program Manager- Maternal HealthTeam
Akshay Mohandas
Application & Sales SpecialistTeam
Kiran B L
Inhouse Service EngineerTeam
Dheeraj B N
Lead Application DeveloperTeam
ASTHA SHRIVAS
Marketing ManagerTeam
Alok Kant
Senior Design Engineer, ElectronicsTeam
Girish Gaikar
Electronics Design EngineerTeam

4 more people are available in the full profile.

Premium access

Complete people profiles for InnAccel

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of InnAccel

Figures of Innaccel Technologies Private Limited, the primary company behind InnAccel, for FY 2024. Revenue was ₹18.80 Cr (+60% year on year). Net loss was -₹10.53 Cr (-56% margin). EBITDA was -₹2.93 Cr (-16% margin). Revenue has grown at a compounded annual rate of +46% over three years and +111% over five years.

  • ₹18.80 CrRevenue · FY 2024 · +60% YoY
  • -₹10.53 CrNet loss · -56% margin
  • -₹2.93 CrEBITDA · -16% margin
  • ₹48 LakhPaid-up capital
  • 41Employees (provident fund records)
  • +46%Revenue CAGR, 3 years
  • +111%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Innaccel Technologies Private Limited are on its company page.

Premium access

Detailed financial statements for InnAccel

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of InnAccel

4 dated milestones of InnAccel across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded InnAccel is founded.
  2. Funding First funding round of $899K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Angel Round, of $573K.

Web traffic of InnAccel

The website of InnAccel (innaccel.com) receives about 1.1K visits a month.

  • Monthly visits
    1.1K

    ▼ 77.3% vs previous month

Similar websites

Websites whose visitors overlap most with InnAccel. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
imbms.com
100%
#4,379,291View details
hpiinc.com
96%
11.8K#2,067,910View details
balpharma.com
95%
3K#7,146,280View details
chchealthwatch.com
chchealthwatch.com
92%
#1,802,673–
cardeahealthcare.in
cardeahealthcare.in
90%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 16 similar websites and full traffic analytics for InnAccel

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 16 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Innaccel

Premium access

Complete news archive for InnAccel

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about InnAccel

InnAccel was founded in 2012 and raised its 1st funding round 4 years after it was founded.

InnAccel is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Siraj Dhanani is the CEO of InnAccel, as recorded in our data. They have also founded this company.

InnAccel is a funded company, having raised a total of $6.06M across 6 funding rounds to date. The company's 1st funding round was a Seed of $898.95K, raised on Jan 2016.

InnAccel has 41 employees.

The primary company behind InnAccel, Innaccel Technologies Private Limited, reported revenue of β‚Ή18.80 Cr for FY 2024, up 60% year on year.

InnAccel was founded in 2012 in Bengaluru, India, as an RD company in the medical devices sector. Operations center on the development and manufacturing of devices that target unmet needs in critical care and maternal and child health. The companys portfolio includes products designed for these areas, with leadership provided by co-founders holding various director roles.

InnAccel offers VapCare, Fetal Lite, and SAANS.

InnAccel has 26 investors. Key investors include ACT Grants, Mount Judi Ventures, B K Achutha, Vijay Prasad, and Amit Mookim.

The valuation of InnAccel is $35.17M as of Apr 2022.

InnAccel operates through Innaccel Technologies Private Limited.

The legal entities of InnAccel currently have 3 directors, including Vijayarajan Alagumalai, Sherif Mohammed Kottapurath, Siraj Salim Dhanani.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available